Close
Close
Treatment Database
gefitinib
Trade Name Iressa
Orphan Indication Epidermal growth factor receptor mutation-positive non-small cell lung cancer
USA Market Approval 13-07-2015
USA Designation Date 26-08-2014
Sponsor AstraZeneca Pharmaceuticals LP
1800 Concord Pike, P. O. Box 8355
Wilmington, Delaware, 19803
More about Non-small cell lung cancer
Free Newsletter
Treatment News
Related Videos
by Abidemi Uruejoma
564 views
by Abidemi Uruejoma
4,168 views
by Abidemi Uruejoma
9,927 views
by Dr. Jules Richard Kemadjou
10,127 views